References
- Goldberg RJ, Gore JM, Alpert JS, et al. Incidence and case fatality rates of acute myocardial infarction (1975–1984): the Worcester Heart Attack Study. Am Heart J 1988: 115(Apr): 761–7
- Gore JM, Goldberg RJ, Alpert JS, et al. The increased use of diagnostic procedures in patients with acute myocardial infarction: a community-wide perspective. Arch Intern Med 1987: 147(Ocr): 1729–32
- Uretsky BF, Farquhar DS, Berezin AF, et al. Symptomatic myocardial infarction without chest pain: prevalence and clinical course. Am J Cardiol 1977: 40(4): 498–503
- The Multicenter Diltiazem Postinfarction Trial Research Group. The effect of diltiazem on mortality and reinfarction after myocardial infarction. N Engl J Med 1988: 319(7): 385–92
- The Multicenter Postinfarction Research Group. Risk stratification and survival after myocardial infarction. N Engl J Med 1983: 309(6): 331–6
- White HD, Norris RM, Brown MA, et al. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 1987: 76(1): 44–51
- Théroux P, Waters DD, Halphen C, et al. Prognostic value of exercise testing soon after myocardial infarction. N Engl J Med 1979: 301(7): 341–5
- Gibson RS, Watson DD, Craddock GB, et al. Prediction of cardiac events after uncomplicated myocardial infarction: a prospective study comparing predischarge exercise thallium-201 scintigraphy and coronary angiography. Circulation 1983: 68(2): 321–36
- Gibson RS. Management of acute non-Q-wave myocardial infarction: role of prophylactic pharmacotherapy and indications for predischarge coronary arteriography. Clin Cardiol 1989: 12(7 Suppl 3): 11126–32
- The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N EnglJ Med 1989: 321(6): 406–12
- Lavie CJ, Gersh BJ. Acute myocardial infarction: initial manifestations, management, and prognosis. Mayo Clin Proc 1990: 65(4): 531–48
- Dittus RS, Roberts SD, Adolph RJ. Cost-effectiveness analysis of patient management alternatives after uncomplicated myocardial infarction: a model. J Am Coll Caidiol 1987: 10(4): 869–78
- Smith HW 3d, Liberman HA, Brody SL, et al. Acute myocardial infarction temporally related to cocaine use: clinical, angiographic, and pathophysiologic observations. Ann Intern Med 1987: 107(1): 13–8
- Squires RW, Gau GT, Miller TD, et al. Cardiovascular rehabilitation: status, 1990. Mayo Clin Proc 1990: 65(5): 731–55
- Sparrow D, Dawber TR. The influence of cigarette smoking on prognosis after a first myocardial infarction: a report from the Framingham study. J Chronic Dis 1978: 31(6–7): 425–32
- Secondary prevention in myocardial infarction survivors. Circulation 1982: 65(1): 216A–219A
- Elwood PC. Aspirin in the prevention of myocardial infarction: current status. Drugs 1984: 28(1): 1–5
- Rossouw JE, Lewis B, Rifkind BM. The value of lowering cholesterol after myocardial infarction. N Engl J Med 1990: 323(16): 1112–9
- Brown G, Albers JJ, Fisher LD, et al. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med 1990: 323(19): 1289–98
- Lavie CJ, O'Keefe JH, Blonde L, et al. High-density lipoprotein cholesterol: recommendations for routine testing and treatment. Postgrad Med 1990: 87(7): 36–51